Roche Holding AG (JOBS), Genentech, Inc. (JOBS) Said Two Drugs Don't Boost Lung Cancer Survival

ZURICH/LONDON, Oct 6 (Reuters) - Roche Holding AG and Genentech Inc said on Monday a study into the benefits of combining their Tarceva and Avastin drugs for lung cancer patients did not show an increase in overall survival.

Back to news